OnKure Therapeutics (OKUR) Other Non-Current Liabilities (2020 - 2026)
OnKure Therapeutics' Other Non-Current Liabilities came in at $12,000 for Q2 2026, down 70.0% from $40,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Going back to Q4 2020, OnKure Therapeutics' Other Non-Current Liabilities data covers 21 quarters.
- Other Non-Current Liabilities carries a five-year compound annual growth rate of -19.7% (FY2020 to FY2025).
- Going back by year, Other Non-Current Liabilities was $7,000 in FY2023 (-75.9%), $29,000 in FY2022 (-93.5%) and $444,000 in FY2021.
- The five-year range for quarterly Other Non-Current Liabilities is $7,000 (Q4 2023) to $1.07 million (Q3 2023).
- Year-over-year, Other Non-Current Liabilities increased in two of the last four quarters, with growth averaging 182.9%.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q1 2025 (growth of 471.4%), and the weakest in Q2 2024 (a decline of 99.1%).
- Business Quant data shows OKUR's Other Non-Current Liabilities at $12,000 (Q1 2026), $12,000 (Q4 2025) and $40,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,168.95 Bn | 1,137.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 642.08 Bn | 560.60 Bn | 17.26 Bn |
| 3 | AbbVie | 500.03 Bn | 473.14 Bn | 12.70 Bn |
| 4 | Merck | 359.04 Bn | 313.42 Bn | 12.21 Bn |
| 5 | Novartis Ag | 301.98 Bn | 265.97 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.05 Bn | 240.74 Bn | 12.86 Bn |
| 7 | Amgen | 241.60 Bn | 197.00 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 192.44 Bn | 166.64 Bn | 6.22 Bn |
| 9 | Pfizer | 171.37 Bn | 118.01 Bn | 10.94 Bn |
| 10 | OnKure Therapeutics | 117.69 Mn | -380.23 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | 40,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 876,000.00 |
| Mar 31, 2023 | 324,000.00 |
| Dec 31, 2022 | 29,000.00 |
| Sep 30, 2022 | 66,000.00 |
| Jun 30, 2022 | 55,000.00 |
| Mar 31, 2022 | 57,000.00 |
| Dec 31, 2021 | 611,000.00 |
| Sep 30, 2021 | 382,000.00 |
| Jun 30, 2021 | 417,000.00 |
| Mar 31, 2021 | 32,000.00 |
API Access
OnKure Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();